LEXICON PHARMACEUTICALS, INC.
Develops gene-based drugs for chronic diseases, including treatments for heart failure.
LXRX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US5288723027
- LEI:
- Country:
- United States of America
- Address:
- 2445 TECHNOLOGY FOREST BLVD., 77381 THE WOODLANDS
- Website:
- https://www.lexpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines. The company pioneers treatments for serious, chronic conditions by leveraging a unique application of gene science and genetics for drug discovery. Its patient-driven approach aims to develop precise medicines to improve and transform lives. A key product in its portfolio is sotagliflozin, an orally-delivered small molecule drug developed to reduce the risk of cardiovascular death and hospitalization for heart failure. Founded in 1995, Lexicon continues to advance its pipeline of drug candidates.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all LEXICON PHARMACEUTICALS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for LEXICON PHARMACEUTICALS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for LEXICON PHARMACEUTICALS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
